Company intelligence / Profile preview

Deep Knowledge Investors

London, England, United Kingdom
Ownership
Private
Development stage
Other
01

Overview

Deep Knowledge Investors appears to refer to the investment and investor-facing activities associated with the Deep Knowledge ecosystem, which includes Deep Knowledge Group and its investment arm Deep Knowledge Ventures. The organization is not a drug developer, pharma company, or healthcare operating company; instead, it focuses on investment, analytics, and capital formation around DeepTech, longevity, biotech, pharma, and related healthcare sectors. Public materials describe Deep Knowledge Ventures as a data-driven investment fund founded in 2014 and Deep Knowledge Group as a broader consortium spanning analytics, investment, and media in AI, longevity, biotech, and pharma. In practice, this entity is best characterized as a healthcare- and longevity-oriented investment organization rather than a therapeutics company with an internal pipeline. Because the exact legal entity name "Deep Knowledge Investors" is not well documented in primary public sources, some fields below are inferred from the broader Deep Knowledge Group / Deep Knowledge Ventures structure.

Industry
Investors
02

Partnerships

King's College London AI-Longevity Consortium

Beyond the preview

Go deeper on Deep Knowledge Investors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deep Knowledge Investors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call